Page 3 - Stock Analysis

Brokerages split on HDB Financial as margins improve but growth lags

In Q3FY26, HDB Financial reported a steady operating performance marked by margin expansion, moderating credit costs and stable asset quality.

ICICI Direct backs Tata Motors CV on strong margins, market leadership

TMCV remains the market leader in MHCVs, with retail market shares of ~49 per cent in heavy CVs, ~37 per cent in passenger buses, and ~30 per cent in light goods vehicles (FY25).

HDFC Life Q3 growth holds firm, margins set to recover; analysts bullish

The insurer reported an 11 per cent year-on-year (Y-o-Y) growth in annualised premium equivalent (APE) at ₹3,970 crore for Q3FY26, broadly in line with industry growth and analyst expectations.

Elara Capital revises Lemon Tree to Accumulate; sees limited value in rejig

As part of the transaction, Warburg Pincus has acquired APG's entire 41 per cent stake in Fleur and committed up to ₹960 crore of primary equity to fund Fleur's growth.

When midcaps blinked: A year of sharp reversals and what lies ahead

A stalled index masked stock-level swings across sectors. Krishna Kant & Ram Prasad Sahu identify the biggest movers of 2025

Infosys stock to open higher on Friday? ADR jumps 10%; FY26 guidance raised

Infosys ADRs surged 10.2 per cent in New York on Wednesday after the company raised its revenue growth guidance for FY26 to 3-3.5 per cent from 2-3 per cent earlier

Nomura initiates coverage on ITC Hotels with 'Buy,' sees 20% upside

The brokerage expects robust margin improvement, strong cash generation and healthy growth in the company's managed hotels pipeline to drive earnings over the medium term.

Nomura initiates Buy on Indian Hotels; cites ADR growth, asset-light model

Nomura has set a target price of ₹830 for the Indian Hotels stock, based on a valuation of 26 times its estimated FY28 EV/Ebitda

ICICI Pru Life Q3 margins expand despite slow premium growth, say analysts

Most analysts highlighted that the insurer's ability to sustain margins despite the loss of GST input tax credit was the key takeaway from the Q3FY26 results.

ICICI Lombard Q3 review: PAT slips YoY; analysts stay bullish on franchise

ICICI Lombard General Insurance recorded a 9.04 per cent year-on-year (Y-o-Y) drop in net profit to ₹659 crore in the October-December quarter of FY26 (Q3FY26), as compared to ₹724.38 crore in Q3 FY25

Brokerages bullish on HCLTech post Q3FY26 results; raise target price

Most brokerages have increased their target on HCLTech on the backdrop of robust growth visibility

Motilal Oswal starts coverage on Canara HSBC Life with 'Buy'; check target

Canara HSBC Life is among India's top 10 life insurance companies and has a well-diversified product mix, MOFSL said

Grasim's diversified growth strategy set for long-term gains: Motilal Oswal

Grasim's chemical segment, India's largest producer of chlor-alkali and epoxy resins, continues to offer a stable growth trajectory.

AGR relief boosts Vodafone Idea outlook; analysts flag spectrum dues risk

Vodafone Idea shares fell 2% despite 10-year AGR moratorium. Analysts cite spectrum dues, funding risks, and limited upside despite cash-flow relief

Eternal's growth rate, risk-reward make it the preferred qcom bet

Competitive pressure in quick commerce to intensify in 2026

APL Apollo Tubes at 'inflection point', says Motilal Oswal; maintains 'Buy'

Motilal Oswal has maintained its 'Buy' call on APL Apollo Tubes with the target price at ₹2,260per share

Motilal Oswal bullish on M&M's healthy launch pipeline; retains 'Buy'

Motilal Oswal expects M&M to deliver a 14 per cent underlying volume (UV) compound annual growth rate (CAGR) over FY25-FY28E.

Execution-driven margin gains support BHEL despite policy overhang

Policy overhang limits near-term stock performance

Sebi notifies new stock broker regulations after over three decades

Following Sebi board approval last month, the Stock Broker Regulations, 2026, have now been notified, replacing the norms set in 1992

Nomura hikes Max Financial's target price as it expects co to outpace peers

The brokerage maintained a 'Buy' rating and a target price of ₹1,935, which implies upside potential of 15.8 per cent from Tuesday's close price.